Skip to main content
PMC home page
Immunology logoLink to Immunology
. 1991 Feb;72(2):282–286.

Reduced numbers of CD4+ suppressor cells with subsequent expansion of CD8+ protective T cells as an explanation for the paradoxical state of enhanced resistance to Leishmania in T-cell deficient BALB/c mice.

J O Hill 1
PMCID: PMC1384497  PMID: 1826673

Abstract

Compared to their normal, T-cell competent counterparts, BALB/c mice that have been thymectomized, lethally irradiated, and reconstituted with bone marrow cells (TXB) were found to be resistant to Leishmania major. Even though TXB mice possess less than 30% of the normal number of T cells in their lymphoid organs, they generated a protective immune response that prevented the progressive multiplication of the parasite in the primary cutaneous lesion and its dissemination to distant visceral sites. Studies of TXB mice depleted of residual CD4+ or CD8+ T cells by systemic monoclonal antibody (mAb) treatment showed that this protective immunity depends on a residual, radio-resistant CD8+ T-cell population, and that it develops in the virtual absence of CD4+ T cells. This immune response can be negated by an infusion of CD4+ T cells from normal susceptible donors, provided that the donor cells are infused before the recipients' response is generated. It is therefore apparant that TXB BALB/c mice are more resistant than T-cell competent BALB/c mice because the former mice lack a threshold number of CD4+ suppressor T cells necessary to down-regulate the induction and expansion of CD8+ protective T cells.

Full text

PDF
282

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Awwad M., North R. J. Cyclophosphamide-induced immunologically mediated regression of a cyclophosphamide-resistant murine tumor: a consequence of eliminating precursor L3T4+ suppressor T-cells. Cancer Res. 1989 Apr 1;49(7):1649–1654. [PubMed] [Google Scholar]
  2. Awwad M., North R. J. Sublethal, whole-body ionizing irradiation can be tumor promotive or tumor destructive depending on the stage of development of underlying antitumor immunity. Cancer Immunol Immunother. 1988;26(1):55–60. doi: 10.1007/BF00199848. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Behforouz N. C., Wenger C. D., Mathison B. A. Prophylactic treatment of BALB/c mice with cyclosporine A and its analog B-5-49 enhances resistance to Leishmania major. J Immunol. 1986 Apr 15;136(8):3067–3075. [PubMed] [Google Scholar]
  4. Blackwell J. M., Roberts B., Alexander J. Response of BALB/c mice to leishmanial infection. Curr Top Microbiol Immunol. 1985;122:97–106. doi: 10.1007/978-3-642-70740-7_15. [DOI] [PubMed] [Google Scholar]
  5. Blackwell J. M., Ulczak O. M. Immunoregulation of genetically controlled acquired responses to Leishmania donovani infection in mice: demonstration and characterization of suppressor T cells in noncure mice. Infect Immun. 1984 Apr;44(1):97–102. doi: 10.1128/iai.44.1.97-102.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Blackwell J. M. Use of immunological manipulations in studying genetically controlled responses to Leishmania donovani infection in mice. Parasitology. 1984 Aug;88(Pt 4):677–679. doi: 10.1017/s0031182000085590. [DOI] [PubMed] [Google Scholar]
  7. Collins F. M., Stokes R. W. Mycobacterium avium-complex infections in normal and immunodeficient mice. Tubercle. 1987 Jun;68(2):127–136. doi: 10.1016/0041-3879(87)90028-6. [DOI] [PubMed] [Google Scholar]
  8. Ebrahimzadeh A., Jones T. C. A comparative study of different Leishmania tropica isolates from Iran: correlation between infectivity and cytochemical properties. Am J Trop Med Hyg. 1983 Jul;32(4):694–702. doi: 10.4269/ajtmh.1983.32.694. [DOI] [PubMed] [Google Scholar]
  9. Essner R., Rhoades K., McBride W. H., Morton D. L., Economou J. S. IL-4 down-regulates IL-1 and TNF gene expression in human monocytes. J Immunol. 1989 Jun 1;142(11):3857–3861. [PubMed] [Google Scholar]
  10. Farrell J. P., Muller I., Louis J. A. A role for Lyt-2+ T cells in resistance to cutaneous leishmaniasis in immunized mice. J Immunol. 1989 Mar 15;142(6):2052–2056. [PubMed] [Google Scholar]
  11. Galli P., Dröge W. Development of cytotoxic T lymphocyte precursors in the absence of the thymus. Eur J Immunol. 1980 Feb;10(2):87–92. doi: 10.1002/eji.1830100204. [DOI] [PubMed] [Google Scholar]
  12. Gillette R. W. Studies of the T-lymphocytes resident in the spleens of thymectomized, irradiated, bone marrow-reconstituted (TXB) mice. Cell Immunol. 1976 Dec;27(2):200–213. doi: 10.1016/0008-8749(76)90229-x. [DOI] [PubMed] [Google Scholar]
  13. Gutstein N. L., Wofsy D. Administration of F(ab')2 fragments of monoclonal antibody to L3T4 inhibits humoral immunity in mice without depleting L3T4+ cells. J Immunol. 1986 Dec 1;137(11):3414–3419. [PubMed] [Google Scholar]
  14. Hill J. O., Awwad M., North R. J. Elimination of CD4+ suppressor T cells from susceptible BALB/c mice releases CD8+ T lymphocytes to mediate protective immunity against Leishmania. J Exp Med. 1989 May 1;169(5):1819–1827. doi: 10.1084/jem.169.5.1819. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hill J. O., Fahey J. R. Leishmania spp.: agar plating as an alternative to limiting dilution and impression smears for the enumeration of viable parasites in tissue. Exp Parasitol. 1987 Feb;63(1):108–111. doi: 10.1016/0014-4894(87)90083-x. [DOI] [PubMed] [Google Scholar]
  16. Hill J. O. Pathophysiology of experimental leishmaniasis: pattern of development of metastatic disease in the susceptible host. Infect Immun. 1986 May;52(2):364–369. doi: 10.1128/iai.52.2.364-369.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Howard J. G., Hale C., Liew F. Y. Immunological regulation of experimental cutaneous leishmaniasis. III. Nature and significance of specific suppression of cell-mediated immunity in mice highly susceptible to Leishmania tropica. J Exp Med. 1980 Sep 1;152(3):594–607. doi: 10.1084/jem.152.3.594. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Howard J. G., Hale C., Liew F. Y. Immunological regulation of experimental cutaneous leishmaniasis. IV. Prophylactic effect of sublethal irradiation as a result of abrogation of suppressor T cell generation in mice genetically susceptible to Leishmania tropica. J Exp Med. 1981 Mar 1;153(3):557–568. doi: 10.1084/jem.153.3.557. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. LeFrancois L., Bevan M. J. A reexamination of the role of LYT-2-positive T cells in murine skin graft rejection. J Exp Med. 1984 Jan 1;159(1):57–67. doi: 10.1084/jem.159.1.57. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Liew F. Y., Hale C., Howard J. G. Immunologic regulation of experimental cutaneous leishmaniasis. V. Characterization of effector and specific suppressor T cells. J Immunol. 1982 Apr;128(4):1917–1922. [PubMed] [Google Scholar]
  21. Liew F. Y., Millott S., Li Y., Lelchuk R., Chan W. L., Ziltener H. Macrophage activation by interferon-gamma from host-protective T cells is inhibited by interleukin (IL)3 and IL4 produced by disease-promoting T cells in leishmaniasis. Eur J Immunol. 1989 Jul;19(7):1227–1232. doi: 10.1002/eji.1830190712. [DOI] [PubMed] [Google Scholar]
  22. Lowenthal J. W., Harris A. W. Activation of mouse lymphocytes inhibits induction of rapid cell death by x-irradiation. J Immunol. 1985 Aug;135(2):1119–1125. [PubMed] [Google Scholar]
  23. Moll H., Mitchell G. F. Analysis of variables associated with promotion of resistance and its abrogation in T cell-reconstituted nude mice infected with Leishmania major. J Parasitol. 1988 Dec;74(6):993–998. [PubMed] [Google Scholar]
  24. Moll H., Scollay R., Mitchell G. F. Resistance to cutaneous leishmaniasis in nude mice injected with L3T4+ T cells but not with Ly-2+ T cells. Immunol Cell Biol. 1988 Feb;66(Pt 1):57–63. doi: 10.1038/icb.1988.7. [DOI] [PubMed] [Google Scholar]
  25. North R. J. Down-regulation of the antitumor immune response. Adv Cancer Res. 1985;45:1–43. doi: 10.1016/s0065-230x(08)60265-1. [DOI] [PubMed] [Google Scholar]
  26. Preston P. M., Carter R. L., Leuchars E., Davies A. J., Dumonde D. C. Experimental cutaneous leishmaniasis. 3. Effects of thymectomy on the course of infection of CBA mice with Leishmania tropica. Clin Exp Immunol. 1972 Feb;10(2):337–357. [PMC free article] [PubMed] [Google Scholar]
  27. Sadick M. D., Heinzel F. P., Holaday B. J., Pu R. T., Dawkins R. S., Locksley R. M. Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon gamma-independent mechanism. J Exp Med. 1990 Jan 1;171(1):115–127. doi: 10.1084/jem.171.1.115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Sado T., Kamisaku H., Aizawa S. Nature of T-cells resident in spleens of thymectomized, lethally irradiated, bone marrow-reconstituted mice. Cell Immunol. 1980 Jan;49(1):51–63. doi: 10.1016/0008-8749(80)90055-6. [DOI] [PubMed] [Google Scholar]
  29. Skov C. B., Twohy D. W. Cellular immunity to Leishmania donovani. I. The effect of T cell depletion on resistance to L. donovani in mice. J Immunol. 1974 Dec;113(6):2004–2011. [PubMed] [Google Scholar]
  30. Titus R. G., Ceredig R., Cerottini J. C., Louis J. A. Therapeutic effect of anti-L3T4 monoclonal antibody GK1.5 on cutaneous leishmaniasis in genetically-susceptible BALB/c mice. J Immunol. 1985 Sep;135(3):2108–2114. [PubMed] [Google Scholar]
  31. Titus R. G., Milon G., Marchal G., Vassalli P., Cerottini J. C., Louis J. A. Involvement of specific Lyt-2+ T cells in the immunological control of experimentally induced murine cutaneous leishmaniasis. Eur J Immunol. 1987 Oct;17(10):1429–1433. doi: 10.1002/eji.1830171007. [DOI] [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES